On April 23, 1908, the creation of the Medical Reserve Corps authorized the placement of several hundred medical personnel on a federal reserve status to be called to active duty if needed to augment the regular medical doctors.
Glyburide (Micronase, Diabeta, Glynase Prestab) is a drug prescribed for the treatment of type 2 diabetes. It is recommended that glyburide be combined with diet and exercise for controlling blood glucose levels. Side effects, drug interactions, dosage, and safety during pregnancy should be reviewed prior to taking this medication.
Ticagrelor (trade name Brilinta, Brilique, and Possia) is a platelet aggregation inhibitor produced by AstraZeneca. Ticagrelor is an antagonist of the P2Y 12 receptor. The drug was approved for use in the European Union by the European Commission on December 3, 2010. The drug was approved by the US Food and Drug Administration on July 20, 2011.